BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 15.2//EN BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:20251102T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11 TZNAME:Eastern Standard Time TZOFFSETFROM:-0400 TZOFFSETTO:-0500 END:STANDARD BEGIN:DAYLIGHT DTSTART:20250301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:Eastern Daylight Time TZOFFSETFROM:-0500 TZOFFSETTO:-0400 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Join the Head and Neck (HN) Disease Group for the second annual Head &\; Neck Cancer Scientific Retreat. Highlighting the diverse head and neck cancer research initiatives at the University of Cincinnati Canc er Center\, this retreat will encompass basic\, translational and clinical investigations. The program is designed to strengthen the collective unde rstanding of disease biology\, tumor-immune dynamics\, therapeutic approac hes and patient outcomes. Sessions will feature updates from clinical tria ls and explore emerging mechanisms of therapy resistance and anti-tumor im mune responses. Keynote speaker Natalie Silver\, MD\, MS\, FACS\, Director of Head &\; Neck Cancer Research at the Cleveland Clinic\, will discus s how integrated analyses of tumor genetics\, intratumoral microbiota and the tumor microenvironment are revealing new insights into immunotherapy r esponse and shaping next-generation combination strategies for patients wi th head and neck cancer.The retreat will provide a collaborative forum for researchers and clinicians to share ideas\, build partnerships and accele rate progress. Industry and clinical sponsors will also be in attendance\, creating opportunities to engage with leaders across clinical\, diagnosti c and pharmaceutical sectors.Notice: This registration is intended for eve nt attendees only. If you are a representative/employee of a pharmaceutica l company that is interested in sponsoring and/or attending\, you must con tact Sydney Kavish.Register Now DTEND:20260508T210000Z DTSTAMP:20260415T020145Z DTSTART:20260508T160000Z LOCATION:OH\,Cincinnati\,2900 Reading Rd. SEQUENCE:0 SUMMARY:2nd Annual Head & Neck Cancer Scientific Retreat UID:RFCALITEM639118153055194408 X-ALT-DESC;FMTTYPE=text/html:

Join the Head and Neck (HN) Disease Group for the second annual Head &\; Neck Cancer Scientific Retreat. Highlighting the diverse head and neck cancer researc h initiatives at the University of Cincinnati Cancer Center\, this retreat will encompass basic\, translational and clinical investigations. The pro gram is designed to strengthen the collective understanding of disease bio logy\, tumor-immune dynamics\, therapeutic approaches and patient outcomes .

Sessions will feature updates from clinical trials and explo re emerging mechanisms of therapy resistance and anti-tumor immune respons es. Keynote speaker Natalie Silver\, MD\, MS\, FACS\, Director of Head &am p\; Neck Cancer Research at the Cleveland Clinic\, will discuss how integr ated analyses of tumor genetics\, intratumoral microbiota and the tumor mi croenvironment are revealing new insights into immunotherapy response and shaping next-generation combination strategies for patients with head and neck cancer.

The retreat will provide a collaborative fo rum for researchers and clinicians to share ideas\, build partnerships and accelerate progress. Industry and clinical sponsors will also be in atten dance\, creating opportunities to engage with leaders across clinical\, di agnostic and pharmaceutical sectors.

Notice: This registration is intended for event attendees only. If you are a representative/employee of a pharmaceutical company that is interested in sponsoring and/or attending\, you must contact Sydney Kavish.

< p>
Register Now
END:VEVENT END:VCALENDAR